PRESCRIBING · PART D · 2024
Total Rx claims
328
Beneficiaries
—
Total drug cost
$417K
Distinct drugs
5
Brand share
10.7%
Top prescribed drugs
Anastrozole242 claims
Letrozole39 claims
Abemaciclib23 claims
Exemestane12 claims
Lapatinib Ditosylate12 claims
QUALITY · MIPS · 2024
Final MIPS score
91.8
Quality
88.8
Cost
74.2
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.71%
Group
CROSS-REFERENCE